Incyte International Locations
NORTH AMERICA—HEADQUARTERS
DENMARK
ITALY
SPAIN
UNITED KINGDOM
EUROPE—HEADQUARTERS
FINLAND
JAPAN
SWEDEN
AUSTRIA
FRANCE
THE NETHERLANDS
SWITZERLAND
CANADA
GERMANY
NORWAY
PORTUGAL
Close
As a science-driven and patient-focused company, Incyte aims to make a difference—for patients, medical professionals, organizations, the broader healthcare community and all of our global stakeholders.
Our Commitment to Patients
Our highly experienced team has built a fully integrated U.S. infrastructure with strong coordination across all functions to successfully deliver on our commitment to patients with previously unmet treatment needs.
Learn more about Jakafi® (ruxolitinib)
Learn more about Pemazyre® (pemigatinib)
Learn more about Monjuvi® (tafasitamab-cxix)
Our Commitment to You and Your Patients
Incyte is committed to helping you positively impact the lives of patients with therapies that fill unmet treatment needs and with programs that remove barriers to access and assist with ongoing support.
Medical Information
Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you are seeking medical information on our products, or wish to meet with a Medical Science Liaison, please visit lncyteMI.com.
To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463).
Incyte is committed to helping you positively impact the lives of patients with therapies that fill unmet treatment needs.
Learn more about Iclusig® (ponatinib)
Global Medical Information
Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you need medical information or have a medical question, please visit incyteglobalmedicalinformation.com.
To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Global Medical Information.
DO YOU WANT TO CONTINUE?